DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
FLG | Filaggrin | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
POU2F3 | POU class 2 homeobox 3 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
SOX10 | SRY (sex determining region Y)-box 10 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
GSDMC | Gasdermin C | Predicted intracellular proteins
| | | | | Group enriched |
TRIM29 | Tripartite motif containing 29 | Predicted intracellular proteins
| | | | | Group enriched |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
EVPL | Envoplakin | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Group enriched |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
DSP | Desmoplakin | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
SFN | Stratifin | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
JUP | Junction plakoglobin | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
SERPINB5 | Serpin peptidase inhibitor, clade B (ovalbumin), member 5 | Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CLCA2 | Chloride channel accessory 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
EPS8L1 | EPS8-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FAM83G | Family with sequence similarity 83, member G | Predicted intracellular proteins
| | | | | Tissue enhanced |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GRHL1 | Grainyhead-like 1 (Drosophila) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
JAG2 | Jagged 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
PKP3 | Plakophilin 3 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PPP1R13L | Protein phosphatase 1, regulatory subunit 13 like | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PTGS1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | Cancer-related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RARG | Retinoic acid receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
SCEL | Sciellin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SPTBN2 | Spectrin, beta, non-erythrocytic 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TFAP2C | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TP73 | Tumor protein p73 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |